Romulus Timar
Romulus Timar is an expert in Endocrinology at Victor Babeș University of Medicine and Pharmacy Timișoara (Romania). As of August 2026, ScienceLeadR ranks Romulus Timar in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders, and in the top 1% of experts in Romania for Body Weight. Romulus Timar has authored 200 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 562 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2010 - 2026
Number : 200
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Renal Effects of Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Disease: A Narrative Review of Mechanisms and Clinical Evidence. PMID 42654406 — diabetes mellitus, kidney diseases, glucagon-like peptide 1, glucagon-like peptide-1 receptor, diabetic nephropathies, kidney, glucagon, glucagon-like peptides, diabetes mellitus, type 2 | Medicina (Kaunas) | 2026 | 0 |
| Determinants of Metabolic Dysfunction-Associated Steatotic Liver Diseases in Patients with Type 2 Diabetes Mellitus. PMID 42652825 — liver diseases, diabetes mellitus, liver, cholesterol, prevalence, risk factors, diabetes mellitus, type 2 | J Clin Med | 2026 | 0 |
| Metabolic Syndrome and Periodontitis-From Shared Mechanisms to Interdisciplinary Care: A Narrative Review of Clinical Evidence. PMID 42513424 — diabetes mellitus, glucagon-like peptide 1, oral health, insulin resistance, insulin, cardiovascular diseases, risk management, periodontal diseases, research, therapeutics, periodontitis, metabolic syndrome, microbiota, diabetes mellitus, type 2, oral microbiome | J Clin Med | 2026 | 0 |
| Effects of Semaglutide on Cardiometabolic Risk in People with Obesity, With and Without Type 2 Diabetes: A Retrospective Observational Study. PMID 42355589 — diabetes mellitus, insulin resistance, insulin, body composition, body weight, obesity, therapeutics, waist circumference, diabetes mellitus, type 2, semaglutide | J Clin Med | 2026 | 0 |
| A Pilot Study of Circulating microRNA Expression in Newly Diagnosed Type 2 Diabetes Using a Pooled Sample Approach. PMID 42346183 — diabetes mellitus, pilot projects, pilots, micrornas, biomarkers, circulating microrna, plasma, diabetes mellitus, type 2 | Clin Pract | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map